Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
8,321,792
-
Share change
-
+667,731
-
Total reported value
-
$638,198,251
-
Put/Call ratio
-
293%
-
Price per share
-
$76.69
-
Number of holders
-
81
-
Value change
-
+$51,685,578
-
Number of buys
-
50
-
Number of sells
-
31
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q1 2014
As of 31 Mar 2014,
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,321,792 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, UBS AG, RAYMOND JAMES & ASSOCIATES, FIRST TRUST ADVISORS LP, LPL Financial LLC, ROYAL BANK OF CANADA, and Valentine Capital Asset Management, Inc..
This page lists
81
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.